Xiaodong Feng

Dr. Xiaodong Feng


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2013 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
XFXiaodong Feng
Xiaodong Feng
KDK. Dong
K. Dong
DPD. Pham
D. Pham
SPS. Pence
S. Pence
JIJ. Inciardi
J. Inciardi
NBN. S. Bhutada
N. S. Bhutada
What is known and Objective Single‐dose rasburicase for the treatment and prevention of hyperuricaemia in adult and paediatric patients with cancer at high risk of tumour lysis syndrome (TLS) has been widely adopted in pharmacy practice as unlabelled use with limited clinical evidence. This meta‐analysis study evaluated the efficacy and cost savings of a single‐dose rasburicase (SDR) regimen compared with the Food and Drug Administration‐approved daily dosing of rasburicase (DDR) for 5 days or the traditional treatment with allopurinol in adult cancer patients with hyperuricaemia or at high risk for TLS. Methods Prospective and retrospective studies were retrieved from a systemic search of major electronic data sources. Studies included in the meta‐analysis were those with SDR for the prophylaxis of high‐risk TLS or treatment of hyperuricaemia in adult patients with cancer. The results of response rate and controlling of time‐dependent plasma uric acid (UA) reduction were pooled and compared with the results from patients treated with DDR for 5 days or patients treated with allopurinol. A cost analysis was performed to analyse the treatment costs for adults with hyperuricaemia or at high risk for TLS. Results and Discussion Ten studies (eight retrospective and two prospective) evaluated the SDR response rate and plasma UA level reduction over time. The pooled total number of patients treated with SDR (from 0·05 mg/kg to 0·20 mg/kg) was 269. The pooled response rate of the SDR arm was not significantly different than that of DDR (0·2 mg/kg) arm (88·15% vs. 90·18%, P = 0·542), but significantly stronger than that of allopurinol (300 mg/day orally days 1 to 5) arm (response rate: 88·15% vs. 66%, P < 0·0005). Pooled SDR group efficiently controlled the plasma uric acid (UA) level below 4·5 mg/dL over 24 h, 48 h and 72 h, whereas DDR reduced plasma UA levels to hypouricaemia level (<2 mg/dl). In addition, cost analysis demonstrated that standard‐dose SDR (≥6 mg) has non‐inferior clinical benefit and significant cost savings compared with the DDR regimen. What is new and Conclusion Single‐dose rasburicase (SDR) for adult cancer patients with hyperuricaemia or at high risk for TLS demonstrated better response rate and stronger control of uric acid level compared with allopurinol. SDR response rate was not inferior to that of DDR, and the standard‐dose SDR generates more cost savings compared with the DDR. It suggests that the single‐dose rasburicase is clinically effective and cost efficient for the prophylaxis of high‐risk TLS and the treatment of hyperuricaemia in adult patients with cancer. Additional randomized control studies are needed to confirm the findings of this meta‐analysis study.

4 June 2022 in Pharmacy
Verified
Journal Article
Open access
PDF file
JCJennifer Courtney
Jennifer Courtney
ETErika Titus-Lay
Erika Titus-Lay
Ashim MalhotraAshim Malhotra
Ashim Malhotra
JNJeffrey Nehira
Jeffrey Nehira
Islam MohamedIslam Mohamed
Islam Mohamed
Ruth VinallRuth Vinall
Ruth Vinall
The COVID-19 pandemic led to many colleges of pharmacy having to make major changes relating to their infrastructure and delivery of their curriculum within a very short time frame, including the transition of many components to an online setting. This scoping review sought to summarize what is known about the impact of COVID-19 on pharmacy education and the effectiveness of adaptation strategies which were put in place. PubMed, Web of Science, OVID Medline, and MedEdPortal were searched to identify pharmacy education-related articles published since the beginning of the COVID-19 pandemic. For article inclusion, the following criteria had to be met: described original research, related directly to PharmD or PharmBS education, related to the impact of COVID-19 on pharmacy education, and was available in English. Out of a total of 813 articles, 50 primary research articles were selected for inclusion. Our review of these identified four domains relating to the impact of COVID-19 on pharmacy education and/or effectiveness of adaptation strategies: (1) lab-based courses and activities (including interprofessional education activities), (2) experiential education, (3) didactic education, and (4) student well-being. The key research findings are summarized and discussed. While the COVID-19 pandemic has clearly brought many challenges to pharmacy education, it has also led to key improvements and innovations.

13 May 2016 in The AAPS Journal
Verified
Journal Article
Closed access
PDF file
YZYingqi Zhang
Yingqi Zhang
SSSeumsack Dennis Somtakoune
Seumsack Dennis Somtakoune
CCChristina Cheung
Christina Cheung
MLMario Listiawan
Mario Listiawan
XFXiaodong Feng
Xiaodong Feng

9 April 2022 in Pharmacy
Verified
Journal Article
Open access
PDF file
Ashim MalhotraAshim Malhotra
Ashim Malhotra
EKEugene Kreys
Eugene Kreys
XFXiaodong Feng
Xiaodong Feng
Ensuring an adequate preparation for undergraduate students transitioning to pharmacy school is challenging. A significant barrier is changing from a subordinate to a critical thinking mindset while self-identifying as a professional. Here, we aimed to (1) determine whether our prepharmacy program called “Professional Identity and Me” (PRIME) could enhance learners’ self-awareness of their professional identity and (2) compare the effectiveness of the in-person and online versions of PRIME. PRIME introduced prepharmacy students to aspects of pharmacists’ professional identity including community, hospital, and interprofessional work, as well as mental health, wellness, and time and stress management skills, Top-200 drugs, prerequisite foundational sciences, and calculations. Concepts of professionalism, graduate writing, and ownership were also presented. Bridging exercises were introduced to exemplify application. We used a mixed-methods approach to assess the outcomes. The average performance in knowledge-based assessments increased before and after the PRIME program from 53.8 to 74.6% and from 47.7 to 75.9%, while the difference in the test scores was statistically significant, with a 21% increase (p < 0.001, 95% CI 15–26%) and a 28% improvement (p < 0.001, 95% CI 23–34%) for face-to-face versus virtual PRIME. The results of a student perception survey revealed PRIME was equally effective as a virtual program during the COVID-19 pandemic, suggesting transferability to other pharmacy programs.

1 July 2022 in Pharmacy
Verified
Journal Article
Open access
PDF file
Ashim MalhotraAshim Malhotra
Ashim Malhotra
SOSong Oh
Song Oh
Zhuqiu JinZhuqiu Jin
Zhuqiu Jin
XFXiaodong Feng
Xiaodong Feng
Pharmacists must integrate foundational sciences with pharmacy practice for providing optimal patient care. Pharmacy students need to be trained to provide culturally competent, linguistically accessible, and empathetic care while integrating foundational science principles. However, such holistic integration is challenging to achieve and assess. To bridge this gap, we implemented and assessed an “integrated cardiovascular simulation” (ICS) module for P2 students, employing case-based and team-based learning. ICS focused on congestive heart failure with preexisting arrhythmia and incorporated patient counseling relating to diversity factors such as cultural competency, linguistic challenges, and the impact of population diversity on cardiac diseases. Students learned the SBAR communication technique (situation, background, assessment, and recommendation) and recommended therapy while elaborating on drug MOA and adverse effects. ICS was assessed through pre-and post-session quizzes and perception data immediately after the activity, and after two years, when students progressed to the cardiovascular APPE block. Student performance improved on a post-test (80.2%) compared to the pre-test (66.9%), p < 0.01 paired student t-test, with an increase in symptom and arrhythmia pattern recognition (41.2% and 36.7%, respectively). ICS was effective for teaching (1) arrhythmia pathophysiology (85%), (2) EKG interpretation (89%), (3) drug adverse effects (93%), (4) DEI-clinical decision making (92%), and (5) communication skills (85%).

25 October 2025 in Biology
Verified
Journal Article
Open access
PDF file
HHHunter Hudgins
Hunter Hudgins
VMValeria Molina
Valeria Molina
SWStanley Wiernicki
Stanley Wiernicki
KOKenneth Okwuegbe
Kenneth Okwuegbe
XFXiaodong Feng
Xiaodong Feng
Hongbin WangHongbin Wang
Hongbin Wang
Emerging evidence reveals a significant shift in understanding the complement system’s role in cancer, where activation of a complement within the tumor microenvironment (TME) fuels tumor growth and metastasis instead of suppressing it. Research highlights C3a and C5a anaphylatoxins as key drivers of cancer progression, showing that the blockade of their signaling pathways can inhibit tumor growth and metastasis. By interacting with immune cells in the TME, including tumor-associated macrophages (TAMs), T cells, and myeloid-derived suppressor cells, C3a and C5a promote immunosuppression, thereby driving cancer cell proliferation, angiogenesis, and metastasis. However, conflicting findings persist, despite growing evidence supporting the role of C3a and C5a in tumor progression and the potential therapeutic benefits of targeting pathological complement activation. This paper presents a systematic review of studies examining the activation of the complement system and the role of the C3a and C5a signaling pathways in the TME, focusing on their effects on tumor progression, their interactions with TME components, and the potential for targeting these signaling pathways to boost anti-tumor immune responses.